Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Diabetic Neuropathy Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Diabetic Neuropathy Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Peripheral Neuropathy
      • 1.3.3 Autonomic Neuropathy
      • 1.3.4 Proximal Neuropathy
      • 1.3.5 Focal Neuropathy
    • 1.4 Market Segment by Application
      • 1.4.1 Global Diabetic Neuropathy Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Retail Pharmacy
      • 1.4.5 Online Pharmacy
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Diabetic Neuropathy Production Value 2014-2025
      • 2.1.2 Global Diabetic Neuropathy Production 2014-2025
      • 2.1.3 Global Diabetic Neuropathy Capacity 2014-2025
      • 2.1.4 Global Diabetic Neuropathy Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Diabetic Neuropathy Market Size CAGR of Key Regions
      • 2.2.2 Global Diabetic Neuropathy Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Diabetic Neuropathy Capacity by Manufacturers
      • 3.1.2 Global Diabetic Neuropathy Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Diabetic Neuropathy Revenue by Manufacturers (2014-2019)
      • 3.2.2 Diabetic Neuropathy Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Diabetic Neuropathy Market Concentration Ratio (CR5 and HHI)
    • 3.3 Diabetic Neuropathy Price by Manufacturers
    • 3.4 Key Manufacturers Diabetic Neuropathy Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Diabetic Neuropathy Market
    • 3.6 Key Manufacturers Diabetic Neuropathy Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Peripheral Neuropathy Production and Production Value (2014-2019)
      • 4.1.2 Autonomic Neuropathy Production and Production Value (2014-2019)
      • 4.1.3 Proximal Neuropathy Production and Production Value (2014-2019)
      • 4.1.4 Focal Neuropathy Production and Production Value (2014-2019)
    • 4.2 Global Diabetic Neuropathy Production Market Share by Type
    • 4.3 Global Diabetic Neuropathy Production Value Market Share by Type
    • 4.4 Diabetic Neuropathy Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Diabetic Neuropathy Consumption by Application

    6 Production by Regions

    • 6.1 Global Diabetic Neuropathy Production (History Data) by Regions 2014-2019
    • 6.2 Global Diabetic Neuropathy Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Diabetic Neuropathy Production Growth Rate 2014-2019
      • 6.3.2 United States Diabetic Neuropathy Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Diabetic Neuropathy Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Diabetic Neuropathy Production Growth Rate 2014-2019
      • 6.4.2 European Union Diabetic Neuropathy Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Diabetic Neuropathy Import & Export
    • 6.5 China
      • 6.5.1 China Diabetic Neuropathy Production Growth Rate 2014-2019
      • 6.5.2 China Diabetic Neuropathy Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Diabetic Neuropathy Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Diabetic Neuropathy Consumption by Regions

    • 7.1 Global Diabetic Neuropathy Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Diabetic Neuropathy Consumption by Type
      • 7.2.2 United States Diabetic Neuropathy Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Diabetic Neuropathy Consumption by Type
      • 7.3.2 European Union Diabetic Neuropathy Consumption by Application
    • 7.4 China
      • 7.4.1 China Diabetic Neuropathy Consumption by Type
      • 7.4.2 China Diabetic Neuropathy Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Diabetic Neuropathy Consumption by Type
      • 7.5.2 Rest of World Diabetic Neuropathy Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Pfizer
      • 8.1.1 Pfizer Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Diabetic Neuropathy
      • 8.1.4 Diabetic Neuropathy Product Introduction
      • 8.1.5 Pfizer Recent Development
    • 8.2 Janssen Pharmaceuticals
      • 8.2.1 Janssen Pharmaceuticals Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Diabetic Neuropathy
      • 8.2.4 Diabetic Neuropathy Product Introduction
      • 8.2.5 Janssen Pharmaceuticals Recent Development
    • 8.3 Eli Lilly and Company
      • 8.3.1 Eli Lilly and Company Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Diabetic Neuropathy
      • 8.3.4 Diabetic Neuropathy Product Introduction
      • 8.3.5 Eli Lilly and Company Recent Development
    • 8.4 ACTAVIS
      • 8.4.1 ACTAVIS Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Diabetic Neuropathy
      • 8.4.4 Diabetic Neuropathy Product Introduction
      • 8.4.5 ACTAVIS Recent Development
    • 8.5 Cephalon
      • 8.5.1 Cephalon Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Diabetic Neuropathy
      • 8.5.4 Diabetic Neuropathy Product Introduction
      • 8.5.5 Cephalon Recent Development
    • 8.6 MEDA Pharma & Co. KG
      • 8.6.1 MEDA Pharma & Co. KG Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Diabetic Neuropathy
      • 8.6.4 Diabetic Neuropathy Product Introduction
      • 8.6.5 MEDA Pharma & Co. KG Recent Development
    • 8.7 GlaxoSmithKline
      • 8.7.1 GlaxoSmithKline Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Diabetic Neuropathy
      • 8.7.4 Diabetic Neuropathy Product Introduction
      • 8.7.5 GlaxoSmithKline Recent Development
    • 8.8 NeuroMetrix
      • 8.8.1 NeuroMetrix Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Diabetic Neuropathy
      • 8.8.4 Diabetic Neuropathy Product Introduction
      • 8.8.5 NeuroMetrix Recent Development
    • 8.9 Johnson and Johnson
      • 8.9.1 Johnson and Johnson Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Diabetic Neuropathy
      • 8.9.4 Diabetic Neuropathy Product Introduction
      • 8.9.5 Johnson and Johnson Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Diabetic Neuropathy Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Diabetic Neuropathy Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Diabetic Neuropathy Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Diabetic Neuropathy Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Diabetic Neuropathy Production Forecast by Type
      • 9.7.2 Global Diabetic Neuropathy Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Diabetic Neuropathy Sales Channels
      • 10.2.2 Diabetic Neuropathy Distributors
    • 10.3 Diabetic Neuropathy Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Growth in global diabetic neuropathy market is highly attributed to consistently increasing diabetic population across the globe linked with growing awareness among people is considered as major market driver for diabetic neuropathy market. Moreover, global market is primarily driven by changing lifestyle which has mostly resulted into unhealthy dietary habits and patterns. In addition, factors such as increasing aging population, rise in healthcare expenditure for diabetes, growing awareness about diabetes, and rise in R&D activities in drug discovery and development have contributed in the global growth. However, growth of this market is predominantly restrained by longer approval time for drugs and side effects and rising cost of diabetic neuropathy treatment. Also, stringent regulatory requirement and significant failure rate during the clinical trials expected to be the growth barriers in the years to come.
      In 2019, the market size of Diabetic Neuropathy is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of 5.0% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diabetic Neuropathy.

      This report studies the global market size of Diabetic Neuropathy, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Diabetic Neuropathy production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer
      Janssen Pharmaceuticals
      Eli Lilly and Company
      ACTAVIS
      Cephalon
      MEDA Pharma & Co. KG
      GlaxoSmithKline
      NeuroMetrix
      Johnson and Johnson

      Market Segment by Product Type
      Peripheral Neuropathy
      Autonomic Neuropathy
      Proximal Neuropathy
      Focal Neuropathy

      Market Segment by Application
      Hospitals
      Clinics
      Retail Pharmacy
      Online Pharmacy

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Diabetic Neuropathy status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Diabetic Neuropathy manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Diabetic Neuropathy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now